AXT (AXTI) Stock: Indium Phosphide Demand, Expansion Funding, and Export Risks

AXT, Inc. (AXTI) reported record third-quarter revenue of $73.4 million, up 162% year over year, and net income of $25.7 million, reversing a loss in the prior-year period. Indium phosphide (InP) revenue reached $54.3 million, while non-GAAP gross margin rose to 56.1%. Demand for substrates used in high-speed optical modules is supporting growth: backlog exceeded $500 million, and management expects fourth-quarter revenue of about $90 million.

To expand capacity, AXT plans to raise up to $545 million through a private-equity financing for its Tongmei operating subsidiary, with a minimum investment of $285 million and an initial closing deadline of December 20, 2026. The company has doubled its InP capacity and is progressing toward four-inch wafer production and six-inch pilot lines, with another capacity expansion targeted for 2027. Funding completion and production ramp-up will affect AXT’s ability to meet demand and deliver on its revenue outlook.

Despite strong results, AXTI has recently traded near $43, well below its 52-week high of $143.16. Valuation adjustment after a sharp run-up, volatility in optical communications stocks, and export-permit approvals remain key risks. Analysts’ average 12-month price targets range from about $78 to $93, but targets do not guarantee future performance. Investors may monitor financing, capacity growth, order fulfillment, and export approvals. This article is for informational purposes only and is not investment advice.